Skip to content

Merck & Co. MRK Deferred Taxes

Deferred Taxes at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$211M-23.6%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$7.01B+189%
Pfizer logo
PfizerPFE
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
Amgen logo
AmgenAMGN
Gilead Sciences logo
Gilead SciencesGILD

Other financials

Income statement

See full
Revenue$16.3B+4.9%
Gross profit$12.1B-0.2%
Net income-$4.2B-183%
EPS (diluted)-$1.72-186%

Balance sheet

See full
Cash & equivalents$5.4B-38.2%
Total debt$49.1B+35.8%
Total equity$45.9B-5.1%
Total assets$128.69B+11.8%

Cash flow

See full
Operating cash flow$3.9B+56.7%
CapEx$991.0M-25.4%
Free cash flow$2.9B+150%

Valuation

See full
Market cap$281.24B+31.2%
Enterprise value$324.94B+34.2%
P/E31.5×+19.2×
P/S4.3×+0.9×

Profitability

See full
Gross margin73.9%-2.5pp
Net margin13.6%-13.7pp

Returns & leverage

See full
Return on equity19%-20.3pp
Debt / equity1.1×+0.3×
Current ratio1.3×-0.1×

Where this comes from

Reported directly by Merck & Co. in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.

The official record: Merck & Co.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merck & Co.'s deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merck & Co.'s deferred taxes?
Merck & Co. (MRK) reported deferred taxes of $1.49B in Q1 2026.
How has Merck & Co.'s deferred taxes changed year-over-year?
Merck & Co.'s deferred taxes increased by 6.0% year-over-year, from $1.41B to $1.49B.
What is the long-term trend for Merck & Co.'s deferred taxes?
Over 5 years (2020 to 2025), Merck & Co.'s deferred taxes has grown at a 7.4% compound annual growth rate (CAGR), from $1.01B to $1.44B.